BetterLife Pharma Inc. BETR
CNSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -327.94% | -7.55% | 57.94% | 56.11% | 83.70% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 196.00% | 108.29% | -142.82% | -141.12% | -168.17% |
| Change in Net Operating Assets | -98.31% | -41.30% | 69.81% | 6,051.55% | 463.56% |
| Cash from Operations | -491.89% | 28.22% | 69.50% | 90.50% | 86.29% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 9,444.00% | -- | -66.43% | -98.36% | -98.36% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 202.15% | -40.95% | -70.16% | -75.16% | -80.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | -100.00% |
| Cash from Financing | 1,135.56% | 10.48% | -68.94% | -90.67% | -90.70% |
| Foreign Exchange rate Adjustments | -66.67% | -- | -- | 0.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 993.45% | 102.41% | 116.04% | 85.25% | -252.91% |